Pomalidomide(pomalyst) 4MG cap
Ended Awarded Last action
- Contract number
- 36C24526N0667
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,422
Award facts
- Contract value 100% obligated
- $16,421.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on June 18, 2026, for Pomalidomide (Pomalyst) 4 mg capsules with a ceiling value of $16,421.95. The call was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a comprehensive master agreement covering drugs and pharmaceuticals across multiple therapeutic areas including oncology and immunology, with a contract ceiling of $12.278 billion extending through April 30, 2029. Performance occurs in Memphis, Tennessee. The order is firm fixed price with an ultimate completion date of June 24, 2026. This delivery order supports the VA's oncology treatment mission for eligible veterans across the Veterans Health Administration network.
Quick answers
Who was awarded contract 36C24526N0667?
36C24526N0667 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on June 18, 2026.
How much is contract 36C24526N0667 worth?
The government has obligated $16,422 on 36C24526N0667. Its current value, with exercised options, is $16,422.
Is contract 36C24526N0667 an order under another contract?
Yes. 36C24526N0667 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0667 competed?
The extent of competition for 36C24526N0667 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award